A Ferrieri
Overview
Explore the profile of A Ferrieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esposito I, de Leone A, Di Gregorio G, Giaquinto S, De Magistris L, Ferrieri A, et al.
World J Gastroenterol
. 2007 Nov;
13(45):6016-21.
PMID: 18023092
Aim: To estimate the prevalence of small intestine bacterial overgrowth (SIBO) among patients with an earlier diagnosis of irritable bowel disease (IBS) in our geographical area, and to collect information...
2.
Loguercio C, Federico A, De Girolamo V, Ferrieri A, Del Vecchio Blanco C
Minerva Gastroenterol Dietol
. 2006 Feb;
49(1):53-62.
PMID: 16481971
Background: Chronic hepatic encephalopathy (HE) represents a frequent and serious complication of chronic liver disease. Aim of the study is to comparatively evaluate the effect of rifaximin, lactitol and their...
3.
Biancone L, Vernia P, Agostini D, Ferrieri A, Pallone F
Curr Med Res Opin
. 2006 Jan;
16(1):14-20.
PMID: 16422030
Unlabelled: The occurrence of intestinal bacterial overgrowth in patients with Crohn's Disease (CD) has been described and antimicrobial treatment has been shown to be effective in reversing this condition. However,...
4.
Venturini I, Ferrieri A, Farina F, Cosenza F, Avallone R, Corsi L, et al.
Drugs Exp Clin Res
. 2005 Oct;
31(4):161-8.
PMID: 16223206
Benzodiazepine-like compounds (BZDs), either taken with the diet or synthesized by intestinal bacterial flora, may represent a precipitating factor for hepatic encephalopathy (HE) in cirrhotic patients. We evaluated whether a...
5.
di Stefano M, Strocchi A, Malservisi S, Veneto G, Ferrieri A, Corazza G
Aliment Pharmacol Ther
. 2000 Aug;
14(8):1001-8.
PMID: 10930893
Background: Simethicone, activated charcoal and antimicrobial drugs have been used to treat gas-related symptoms with conflicting results. Aim: To study the relationship between gaseous symptoms and colonic gas production and...
6.
DellAnna A, Azzarone P, Ferrieri A
Eur Rev Med Pharmacol Sci
. 2000 May;
3(3):105-10.
PMID: 10827812
Background: It has been recently shown that Rifaximin, although given as a suspension, plus omeprazole, may be a promising antibiotic against Helicobacter pylori (H pylori) and worthy of further study....
7.
di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza G
Aliment Pharmacol Ther
. 2000 May;
14(5):551-6.
PMID: 10792117
Background: Bacterial overgrowth of the small intestine is a condition characterized by nutrient malabsorption due to an excessive number of bacteria in the lumen of the small intestine. Current treatment...
8.
Gionchetti P, Rizzello F, Venturi A, Ugolini F, Rossi M, Brigidi P, et al.
Eur Rev Med Pharmacol Sci
. 2000 Mar;
3(1):27-30.
PMID: 10710827
The etiology of inflammatory disease is still unknown, but a body of evidence from clinical and experimental observation indicates a role for intestinal microflora in the pathogenesis of this disease....
9.
Amenta M, Dalle Nogare E, Colomba C, Prestileo T, Di Lorenzo F, Fundaro S, et al.
J Chemother
. 2000 Jan;
11(5):391-5.
PMID: 10632386
In HIV-1 infected patients severe enteritis and chronic diarrhea are often documented as a consequence of multiple opportunistic infections. We analyzed 48 HIV-1 positive patients for the presence of intestinal...
10.
Gionchetti P, Rizzello F, Ferrieri A, Venturi A, Brignola C, Ferretti M, et al.
Dig Dis Sci
. 1999 Jul;
44(6):1220-1.
PMID: 10389700
No abstract available.